Your location:

Master e-class invites global professors in the field of neurology and brain sciences to deliver lecture on Alzheimer's disease, GV-971, brain-gut axis, neuro-inflammation and others.
-
Jeffrey CummingsWorld-renowned neurologist, winner of the Bengt Winblad Lifetime Achievement Award (2018) from the US Alzheimer’s Association, and Professor at the Cleveland Clinic Lou Ruvo Center for Brain Health.2022-06-14Global Progress in the Diagnosis and Treatment of Alzheimer's Disease
-
Jeffrey CummingsWorld-renowned neurologist, winner of the Bengt Winblad Lifetime Achievement Award (2018) from the US Alzheimer’s Association, and Professor at the Cleveland Clinic Lou Ruvo Center for Brain Health.2022-06-17Treating Alzheimer’s Disease with GV-971: An International Perspective
-
Zhang JingVice President of Green Valley Research Institute and Director of the Department of Biology.2022-06-14GV-971, China-Developed Novel Drug for Treating AD: Reconditioning the Gut Microbiota and Reducing Neuroinflammation
-
Philip ScheltensDirector of the Alzheimer Center at Amsterdam UMC.2022-06-14Current Status of the Clinical Use of Biomarkers
-
Eric ReimanExecutive Director and CEO of Banner Alzheimer’s Institute.2022-06-14Looking to the Future: Advances in Biomarkers in AD Research and Treatment
-
Xin XianliangDirector of the GV-971 R&D Project at Green Valley Research Institute, as well as one of the key inventors of GV-971.2022-06-14Interpretation of Phase-3 Clinical Results of GV-971, a Novel Drug for Treating AD
-
Sangram SisodiaThomas Reynolds Sr. Family Professor of Neuroscience at the University of Chicago.2022-06-14Regulation of Amyloid Deposition and Neuroinflammation by the Gut Microbiota
-
Kuang WeihongChief Physician and Deputy Director of the Mental Health Center at West China Hospital.2022-06-14Evidence-Based Practice of Antipsychotics in the Treatment of BPSD
-
Yu JintaiChief Physician and Doctoral Supervisor of the Department of Neurology at Huashan Hospital Affiliated to Fudan University.2022-06-14New Progress in the Prevention and Treatment of Alzheimer's Disease
-
Chen ShengdiChief Physician and Doctoral Supervisor at Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine.2022-06-17A Preliminary Study on the Clinical Correlation between the Gut Microbiota and AD and Its Mechanism
-
Luo BenyanDirector of the Neurology Department at the First Affiliated Hospital of Zhejiang University and Qiushi Distinguished Physician of Zhejiang University.2022-06-17Changes in the Gut Microbiota of AD patients and Their Correlation with Cognitive Impairment
-
Sangram SisodiaThomas Reynolds Sr. Family Professor of Neuroscience at the University of Chicago.2022-06-17The Gut-Brain Axis in Health and Disease